{"name":"Shionogi Apnimed Sleep Science","slug":"shionogi-apnimed-sleep-science","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Sivopixant","genericName":"Sivopixant","slug":"sivopixant","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Sivopixant","genericName":"Sivopixant","slug":"sivopixant","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBGdVI0RElNdWN2RDBpRUJRZVJ1T3pKVTdvM2hlMnJXYmtLU2VkRXUyUUJGV25SLXVhWFRBNFFjVHpoSkpHNkNxSTNBT3ZvTTVoVDNV?oc=5","date":"2026-04-06","type":"pipeline","source":"FirstWord Pharma","summary":"Biopharma bites: Apnimed stocks up for sleep apnoea launch, plus Praxis' seizure success - FirstWord Pharma","headline":"Biopharma bites: Apnimed stocks up for sleep apnoea launch, plus Praxis' seizure success","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNek01WDMweU9WS0ZfY0ota1c1WmVHRkdncHMzRUx2cFhGVnNkaHRKV09KNFFJOWtvMXlvNkdpQkU3cndNM1lVbmdHUkhHaDE4WFdDbFExSVF0RVh6T0pkeENIbTl2cUhLWEUtM3dIT181bF9jR3FVcTdXeEJpX0cyN203aVRQVTlQMjFEZDEwM0lMV0tzTXUtQnk1RU5GWU85WERLMTNhcUc2RW04Tl8yRGhwdmpnQ2VDb05RYjZLZ3ROSVdRR0NVWXV6bnJtY3A0OUE?oc=5","date":"2026-03-25","type":"deal","source":"Pharmaceutical Executive","summary":"Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science - Pharmaceutical Executive","headline":"Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5BMExwQnE0S0U4aGF3QXJnVnN6b3o0R25yRERMS2VwcXBhSjVVRjJPNTR3VWY4c2dYWFBFSkFnWGVqbkc0M3BBQ3B4anExbjNxOFRQcUxSU3V2V1YwUDlhUDBVNmZzcnNUQ3F0ekotbUVVU0ROZmdWLWRGZw?oc=5","date":"2026-03-25","type":"deal","source":"The Pharma Letter","summary":"Shionogi to buy out Apnimed stake in JV - The Pharma Letter","headline":"Shionogi to buy out Apnimed stake in JV","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxNM0Npa092c196VWcwM2ZvclFjZTdLUjN1ZTktN1BySDVNVzhtdVZ1Mk9YeXV0dmlJenRnZ3B3ZjRRQzVYcS1tRzRmb0dIRWd3NW9Vd2Z2NnBQdG43XzhLbVFaQ0pqRFdhdlpSZldfTXdNU1RwMmZSZm96NmJlNG45czZIdGZwa0NHRnRHeGpJakVzNUJPUnAxa2VmbTBJdW5YWWVDaFRyVzhXWlYtVTZ0alctMV9GOFcxdW15S1ZIUzA2R1ZGcU52M2dySnRCMTRveS1KZmZ4OENJeTZjRzNMMDFOSkw5NUF3T1VPUm5hcXNjcHFfYzlsVjBmUW1NWnV4S2NMa0toUHVGWDNZQ3pheExHeVBnbzNOVXpTUmg3WjRLbll2UHlmbDFmaE5Xbkw3bHhoM1lfYVNvcUFBbGJ3UEo3VzVJdzdFeFVDU0RqaDI4aEg0WkZJ?oc=5","date":"2026-03-24","type":"pipeline","source":"PR Newswire","summary":"Apnimed Announces Strategic Monetization of Shionogi-Apnimed Sleep Science (SASS) Joint Venture Stake for $150M and Royalties, Strengthening Focus on its Wholly-Owned OSA Program, AD109 - PR Newswire","headline":"Apnimed Announces Strategic Monetization of Shionogi-Apnimed Sleep Science (SASS) Joint Venture Stake for $150M and Roya","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQQlU2MVdtLWNJaHBGNVg4UWFmUnJpcDlzUUp2akhvbUZMUkhRODZsNHk0RDFUck9mSUxOMlRxZDU0SU9PNnpYVFlkT0hGZ2diRnE5Q3Q2dlNjbVVOeVFpOE1hb1hQWllwMWx1aUhrTFU4dm5mVjk3NzNGWU1aSEg2VWstN2F0LXc3N3lCVkU4RWhDTExWdGx6TWtDV29INjZrODJpNDlEUVVlUQ?oc=5","date":"2026-03-24","type":"pipeline","source":"Fierce Biotech","summary":"Shionogi pays Apnimed $100M for joint venture to awaken sleep disorder dream - Fierce Biotech","headline":"Shionogi pays Apnimed $100M for joint venture to awaken sleep disorder dream","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9KZHZvWXRWTlpURDNuWUdSVUREVlVDUll2bGcyVXhTMDFWaU1KZVBYME91a184em9Tb3NUUzFNd2VUM19MeVJ1NXZhQjFtV2RFVEp3?oc=5","date":"2026-03-24","type":"deal","source":"FirstWord Pharma","summary":"Shionogi buys out Apnimed's stake in sleep-focused joint venture for $100M - FirstWord Pharma","headline":"Shionogi buys out Apnimed's stake in sleep-focused joint venture for $100M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOeHg4UTFxM0VWS0U3S3g2R1A2M1VxNzJPdUdhUHcxdGdtdngzLVFzSTRYekpSSUFMZkRLSUJMQ2thVm5KTU1aRXM4RW9HTWo5TU1fdVZFZ2hzZzU0WTFjTlpiNHdHeVFFa3lhU1BBcENodDJUdXMxQ01PSDRkanlKLWNwaV8tbC1pelpaLXFTMHE1cGtjSy0taU4tVS00Q05CaG95X0xxYkZjdldMWnBnZTEyUk5jNmNVV1E?oc=5","date":"2026-03-24","type":"regulatory","source":"AD HOC NEWS","summary":"Shionogi & Co Ltd stock surges on $100M Apnimed deal and Xocova approval boost - AD HOC NEWS","headline":"Shionogi & Co Ltd stock surges on $100M Apnimed deal and Xocova approval boost","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxONGJETUlwaUNwUlRYZDE4M2NESlBwZnNzc3pXbXhiWmMzeEFsNnFrSU1feTRoV2pVMXhnVk0yTHlGRGdSRC1CX2V6SGRIYl8temVFaTBBSzdJbExXWGNwU1lwemNiZkdsMkhtOHlwY0hYc0U0ZFlSTVFPTDFTS0VYRDJLVkk1MExlUzFhMw?oc=5","date":"2025-07-16","type":"trial","source":"Yahoo Finance","summary":"Obstructive Sleep Apnea Clinical Trial Pipeline Expands as 12+ Companies Driving Innovation in OSA Therapeutics | DelveInsight - Yahoo Finance","headline":"Obstructive Sleep Apnea Clinical Trial Pipeline Expands as 12+ Companies Driving Innovation in OSA Therapeutics | DelveI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQbFFCTFRUUGZnRHJLa3BaRmJaSll2R1dzTzBZWkN0YmEtcXd0a2ZGcDhIcng4aUZ1U2htRzRFcWNGSWVuel9fXzM5QTZkTVMwSllDejZEZDhfMUJPMTMyM0h6SG43b3NicWhUb1BZYkdOSV9FaVJNZXhveHVqcm5sZzFpVWNndHpfTnlDVW9CbXFkZmZEdkpXSWc2RQ?oc=5","date":"2025-05-20","type":"trial","source":"The Pharma Letter","summary":"Apnimed touts Phase III success for first-ever sleep apnea pill - The Pharma Letter","headline":"Apnimed touts Phase III success for first-ever sleep apnea pill","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQSS1Gbk1FWXEtRk5kS2lua0VxSVJTdUVvUWtKM2kyWURJVHEtR2pmaGY5bmRPOWZUS1hTQWF6aXpKSDlpdnBHdFE4dHdHSE9kZ1o3VjBUT18tY3ZFTHd2V2V1dndHWHJYRkFkZ2REbm5kZEpadWo1VUFkT1Y1R3huYzQxVEhEOHpzSko1SWVGcDh3WmIyZU04ckdzYlFmU1JuMUlBdEZJZkw1bEwzdmlpVUVJSEZfWDNkbEcxS0VMa1BUVHJyU0RUUmxXV3hrME5JWUVZcWZQblBadDBkZlhBMA?oc=5","date":"2025-04-25","type":"deal","source":"Sleep Review","summary":"Apnimed Acquires Global Rights to Additional Sleep Apnea Drug Candidate - Sleep Review","headline":"Apnimed Acquires Global Rights to Additional Sleep Apnea Drug Candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE1Ob3Jxa3BYTUZUUUg0RmtYSjA3X2xvSGliazhRc2tUNWwyaGw3OEtvT2FCNG94RU1IRGZleVhvZzJBNzM2TEM5NFdwNkNqV3R1bjBHWS00eDNtREJiaUt2YkhpQTNxakExaWpnSEZSbw?oc=5","date":"2025-04-08","type":"trial","source":"Clinical Trials Arena","summary":"Apnimed doses first subject in trial for sleep apnoea with central component - Clinical Trials Arena","headline":"Apnimed doses first subject in trial for sleep apnoea with central component","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQOG1BNzhxbG9LY3NXaG52TmNPdzVWRnZoak5Gd1dvUVpuSXpNMGltcW9rRGpWTFZ4RnlpTmIwT1BDajRhWU5TdVlPeUJDMUV5VTQ0TWdDdHFBTm1mZlA5ejJhNlNMcGdITkEzSGNYQWw0Z1Fjblo2akU0dE9MLW8wM2wtMXVhZHRqTDQ5TDYyWjhrNDROU0l0el9RYjhGdmZQd3RtMTY0c0FZSEhDZzBDVk1SZl9tRml0ZW5sWDNB?oc=5","date":"2025-04-07","type":"pipeline","source":"PR Newswire","summary":"Apnimed Provides Clinical Updates for Multiple Product Candidates - PR Newswire","headline":"Apnimed Provides Clinical Updates for Multiple Product Candidates","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}